首页> 外文期刊>Research Journal of Pharmaceutical, Biological and Chemical Sciences >Screening of CTX-M Type Extended Spectrum BETA-Lactamases Producing Clinical Isolates from Tamil Nadu, India.
【24h】

Screening of CTX-M Type Extended Spectrum BETA-Lactamases Producing Clinical Isolates from Tamil Nadu, India.

机译:从印度泰米尔纳德邦生产临床分离株的CTX-M型超广谱BETA-内酰胺酶的筛选。

获取原文
           

摘要

ABSTRACT The world is facing a major problem of antimicrobial resistance that is more severe in developing countries where the infectious diseases get spread more easily and the cost of treatment and prevention of them is very high. Multidrug resistance and extended spectrum -lactamases (ESBL) production is a common problem, which needs empirical therapy to overcome and to reduce this drug resistance. In this study 88 clinical isolates were studied for ESBL production and presence of CTX-M geno.
机译:摘要世界正面临着一个重要的抗菌素耐药性问题,在发展中国家,传染病更容易传播,治疗和预防这些疾病的费用非常高,这在发展中国家尤为严重。多药耐药性和广谱内酰胺酶(ESBL)的产生是一个普遍的问题,需要经验疗法来克服和降低这种耐药性。在这项研究中,研究了88种临床分离株的ESBL产生和CTX-M基因的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号